NPR logo

Heparin Hearing on Capitol Hill Turns Feisty

  • Download
  • <iframe src="https://www.npr.org/player/embed/89850138/89850099" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Heparin Hearing on Capitol Hill Turns Feisty

Health Care

Heparin Hearing on Capitol Hill Turns Feisty

Heparin Hearing on Capitol Hill Turns Feisty

  • Download
  • <iframe src="https://www.npr.org/player/embed/89850138/89850099" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The head of the Food and Drug Administration Andrew von Eschenbach testifies before a House subcommittee about planned improvements to oversee the foreign manufacture of drug ingredients. The hearing comes after tainted batches of the blood thinner Heparin were linked to a dozen Chinese companies.

Marcia Crosse, a health care director for the Government Accountability Office who testified at the hearing, talks with Melissa Block about how much it would cost to inspect foreign drug plants.